TE KRONNIE, GEERTRUIJ
 Distribuzione geografica
Continente #
NA - Nord America 6.985
EU - Europa 684
AS - Asia 348
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 2
Totale 8.025
Nazione #
US - Stati Uniti d'America 6.980
CN - Cina 326
FI - Finlandia 167
IT - Italia 126
DE - Germania 103
SE - Svezia 101
UA - Ucraina 63
GB - Regno Unito 60
RU - Federazione Russa 10
CH - Svizzera 9
HK - Hong Kong 9
FR - Francia 8
NL - Olanda 8
GR - Grecia 7
IE - Irlanda 6
TR - Turchia 6
CA - Canada 5
BE - Belgio 3
EU - Europa 3
IN - India 3
BG - Bulgaria 2
BR - Brasile 2
DK - Danimarca 2
ES - Italia 2
SI - Slovenia 2
AU - Australia 1
BN - Brunei Darussalam 1
CL - Cile 1
JP - Giappone 1
LI - Liechtenstein 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SG - Singapore 1
Totale 8.025
Città #
Fairfield 1.155
Woodbridge 818
Ann Arbor 638
Chandler 605
Houston 587
Ashburn 469
Wilmington 432
Cambridge 427
Seattle 412
Jacksonville 312
Princeton 147
San Diego 136
Beijing 93
Des Moines 88
Medford 87
Nanjing 80
Roxbury 68
Helsinki 62
Padova 58
Boardman 50
Guangzhou 22
London 22
Shenyang 19
Hebei 18
Falls Church 17
Changsha 14
Jiaxing 14
Nanchang 13
New York 12
Hong Kong 8
Norwalk 8
Milan 7
Redwood City 7
Borås 6
Dublin 6
Ogden 6
Hefei 5
Amsterdam 4
Chiswick 4
Jinan 4
Tianjin 4
Turin 4
Brussels 3
Chiampo 3
Dearborn 3
Fuzhou 3
Indiana 3
Istanbul 3
Kilburn 3
Ningbo 3
Tappahannock 3
Zhengzhou 3
Aprilia 2
Bassano del Grappa 2
Cadoneghe 2
Catania 2
Chicago 2
Copenhagen 2
Edinburgh 2
Fort Worth 2
Genoa 2
Haikou 2
Hangzhou 2
Kharkiv 2
Kunming 2
Lappeenranta 2
Ljubljana 2
Munich 2
Orta 2
Rockville 2
San Francisco 2
Sant'elena 2
Shanghai 2
Sofia 2
Southwark 2
São Paulo 2
Vicenza 2
Washington 2
Wuhan 2
Aberdare 1
Acton 1
Arzignano 1
Bandar Seri Begawan 1
Belgrade 1
Birmingham 1
Bonn 1
Breda 1
Brisbane 1
Bucharest 1
Cislago 1
Citta Sant'angelo 1
Cittadella 1
Costa Mesa 1
Dallas 1
Dalmine 1
Dresden 1
Easton 1
Enschede 1
Hamilton 1
Hanover 1
Totale 7.053
Nome #
Drosophila CAKI/CMG protein, a homolog of human CASK, is essential for regulation of neurotransmitter vesicle release 138
CirComPara: a multi-method comparative bioinformatics pipeline to detect and study circRNAs from RNA-seq data. 134
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL 134
Post-transcriptional silencing and functional characterization of the Drosophila melanogaster homolog of human Surf1 122
Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma. 118
Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients 115
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups. 109
Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways 108
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 105
An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts 105
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 105
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group 102
CircRNAs in hematopoiesis and hematological malignancies 102
The MLL recombinome of acute leukemias in 2013. 101
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts 100
Wnt activation promotes neuronal differentiation of Glioblastoma 99
Somatic mutations activating Wiskott-Aldrich syndrome protein concomitant with RAS pathway mutations in Juvenile myelomonocytic leukemia patients 99
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia 94
Reverse Phase Protein Array (RPPA) of High Risk ALL 93
Sensing protein antigen and microvesicle analytes using high-capacity biopolymer nano-carriers 92
Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia 92
Muscle plasticity and high throughput gene expression studies 91
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study. 91
Wnt signaling promotes phenotypic reprogramming of glioblastoma-derived cells in the zebrafish brain microenvironment 91
Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia 90
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. 89
Wnt activation promotes neuronal differentiation of Glioblastoma. 89
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia 89
Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation. 88
PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy 87
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. 86
Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study 86
DNA methylation and targeted sequencing of methyltransferases family genes in canine acute myeloid leukaemia, modelling human myeloid leukaemia 86
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects. 85
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. 85
AMPK INHIBITION INDUCES APOPTOSIS IN PEDIATRIC B-ALL CELLS WITH MLL GENE REARRANGEMENTS 84
Molecular Mechanisms of HIF-1 alpha Modulation Induced by Oxygen Tension and BMP2 in Glioblastoma Derived Cells 83
Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. 82
Immunophenotype segnature as a tool to define prognostic subgroups in childhood acute myeloid leucemia. 80
MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study 79
Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome. 78
Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALL. 78
Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. 78
Large-scale circular RNA deregulation in T-ALL: Unlocking unique ectopic expression of molecular subtypes 78
Microvesicles Transcripts As Hallmark and Vector From Leukemic Parental Cells 76
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 76
CircRNAs in hematopoiesis and hematological malignancies 76
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories. 75
Computational analysis of flow cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: a MLL/AF4 identification 75
Non-medical applications of non-invasive prenatal diagnosis: Ethical issues. 73
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 72
Genomics and drug profiling of fatal TCF3-HLFâ 'positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options 72
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. 71
Functional role of neurexin molecular complex in synaptic neurotrasmitter release 71
Application of a cDNA microarray for the analysis of muscular dystrophies and childhood leukemias 71
Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia. 70
Validation by RQ-PCR and flow cytometry of alpha-defensin 1-3 (DEFA 1-3) overexpression in relapsed and refractory acute lymphoblastic leucemia. 68
STAT5 Phosphorylation Status by Flow Cytometry Is a Rapid and Reliable Tool for Diagnosis and Follow up of Juvenile Myelomonocytic Leukemia 68
New data on robustness of gene expression signatures in leucemia: Comparison of three distinct total RNA preparatin procedures. 68
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? 68
CI-FISH, GEP, and SNPs Correlate Genomic Categories with Risk Stratification in Children with T-ALL 67
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL 67
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? 66
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model. 66
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B cell precursor acute lymphoblastic leukemia 66
CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands Out 66
Ultrafast molecular motor driven nanoseparation and biosensing. 65
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5. 65
New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia. 65
MICROARRAYS AND 2-D GELS: NEW TOOLS FOR POST-GENOMIC MUSCLE BIOLOGY 64
Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia. 64
Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations. 64
A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia 64
Antibodies covalently immobilized on actin filaments for fast myosin driven analyte transport. 64
Hypoxia and HIF1 alpha Repress the Differentiative Effects of BMPs in High-Grade Glioma 63
Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma. 63
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia. 63
Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia 62
Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia 61
Wnt signaling promotes phenotypic reprogramming of glioblastoma-derived cells in the zebrafish brain microenvironment 60
Sample solution constraints on motor-driven diagnostic nanodevices 59
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia 57
Phosphoproteomic profiling of pediatric B-ALL identifies in mill patients a new signaling pathway for targeted therapy 57
Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group 56
Fiber type specification in vertebrate skeletal muscle 54
CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities 53
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. 52
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients. 52
Hepatocyte growth factor receptor c-MET is associated with FAS when activated enhances drug-induced apoptosis in pediatric B-acute lymphoblastic leukemia with TEL-AML1 translocation. 51
HIGH FIDELITY OF GENE EXPRESSION PROFILES IN SERIAL PEDIATRIC NOD/SCID/HUALL XENOGRAFTS 49
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia. 45
null 44
Effetti del silenziamento di E2A-PBX1 in cellule leucemiche di tipo Pre-B. 44
Mosaic Distribution of RAS Pathway Mutated and Non Mutated Cells in Bone Marrow of Juvenile Myelomonocytic Leukemia. 44
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 44
MicroRNA-497/195 is tumor-suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia 44
Zebrafish brain represents a reliable niche for xenotransplanted human glioblastoma derived cells 43
GENE EXPRESSION PROFILING INDICATES A DOMINANT NEGATIVE ROLE OF PAX5/TEL ON ENDOGENOUS PAX5 IN PRE-BI CELLS 43
PHOSPHOPROTEOMIC PROFILING OF PEDIATRIC T-LINEAGE ACUTE LYMPHOBLASTIC 43
MLL partner genes specify distinct biological and clinical signatures in pediatric acute myeloidleukemia. An AIEOP study. 41
Totale 7.630
Categoria #
all - tutte 26.698
article - articoli 25.077
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 123
Totale 51.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019653 0 0 0 0 0 0 0 0 0 133 282 238
2019/20201.696 260 45 22 121 178 151 158 200 205 187 107 62
2020/20211.223 67 87 29 120 93 104 82 116 206 102 163 54
2021/20221.567 41 179 239 96 70 86 88 160 76 36 167 329
2022/20231.191 240 123 30 164 188 148 3 86 124 14 59 12
2023/2024331 19 71 65 31 27 39 26 25 14 14 0 0
Totale 8.103